Miho Hida
Overview
Explore the profile of Miho Hida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamano N, Komaba H, Tanaka H, Takahashi H, Takahashi Y, Hyodo T, et al.
Am J Nephrol
. 2025 Feb;
:1-9.
PMID: 39978330
Introduction: Recent experimental studies have reported that fibroblast growth factor 23 (FGF23) inhibits erythropoiesis by suppressing erythropoietin (EPO) production and downregulating the EPO receptor. Conversely, either endogenous or exogenous EPO...
2.
Soeda K, Komaba H, Nakagawa Y, Kawabata C, Wada T, Takahashi H, et al.
J Nephrol
. 2024 Mar;
37(5):1339-1349.
PMID: 38512372
Background: Hyponatremia is implicated in pathological bone resorption and has been identified as a risk factor for bone fracture in the general population. However, there are limited data on the...
3.
Nakagawa Y, Komaba H, Wada T, Takahashi H, Takahashi Y, Hyodo T, et al.
Am J Nephrol
. 2022 Dec;
53(11-12):767-774.
PMID: 36574760
Introduction: Sclerostin is an osteocyte-derived inhibitor of bone formation and is increased in kidney failure. Sclerostin might be involved in the pathogenesis of vascular calcification, but few studies have examined...
4.
Kato M, Urabe S, Matsuzawa S, Kato A, Fukazawa M, Hiyama E, et al.
J Artif Organs
. 2022 Feb;
25(4):377-381.
PMID: 35226230
It was reported that amino acid infusion during hemodialysis is useful for improving nutritional status. The optimal administration method of amino acid infusion under the high-volume pre-dilution on-line HDF (HVPO-HDF)...
5.
Nakagawa Y, Komaba H, Hamano N, Tanaka H, Wada T, Ishida H, et al.
J Clin Endocrinol Metab
. 2021 Aug;
107(1):e95-e105.
PMID: 34423837
Context: Sclerostin is an osteocyte-derived inhibitor of bone formation and is increased in kidney failure, but its role in the pathogenesis of renal bone disease remains unknown. Objective: We aimed...
6.
Toyoda M, Murata T, Saito N, Kimura M, Takahashi H, Ishida N, et al.
Ther Apher Dial
. 2021 Jan;
25(5):586-594.
PMID: 33403763
FreeStyle Libre has been approved for use in patients undergoing hemodialysis (HD) in Japan, unlike Europe and the United States; however, evidence regarding its accuracy in such patients is sparse....
7.
Nakagawa Y, Komaba H, Hamano N, Wada T, Hida M, Suga T, et al.
Kidney Int
. 2020 Jul;
98(4):970-978.
PMID: 32682522
The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) guideline update suggests bone mineral density testing to assess fracture risk in patients with chronic kidney disease, but dual-energy X-ray absorptiometry is...
8.
Urabe S, Hyodo T, Hosono T, Kurata Y, Kitamura M, Hida M, et al.
J Artif Organs
. 2020 May;
23(4):342-347.
PMID: 32418159
In this study, we investigated differences in amino acid losses between HD and pre-dilution on-line HDF with equal Kt/V for urea to determine which modality removes less amino acids from...
9.
Urabe S, Hosono T, Hyodo T, Kitamura M, Hida M, Kurata Y, et al.
J Artif Organs
. 2019 Mar;
22(3):253-255.
PMID: 30919160
Background: We encountered a case of unstable predilution online HDF due to elevated transmembrane pressure (TMP) when performing constant-speed predilution online hemodiafiltration (HDF) as treatment for restless legs syndrome (RLS)...
10.
Komaba H, Kakuta T, Wada T, Hida M, Suga T, Fukagawa M
Nephrol Dial Transplant
. 2018 Apr;
34(2):318-325.
PMID: 29672760
Background: Hyperphosphatemia and poor nutritional status are associated with increased mortality. Lanthanum carbonate is an effective, calcium-free phosphate binder, but little is known about the long-term impact on mineral metabolism,...